Skip to main content

Devices and technology: Glycemic control

medwireNews

03-01-2023 | Flash glucose monitoring | News

One-off pre-consultation isCGM use helpful in type 2 diabetes

A short period of intermittently scanned continuous glucose monitoring prior to a first endocrinologist consultation can improve glycemic outcomes for people with type 2 diabetes, report the SPOT FIRST study researchers.

10-25-2022 | Devices and technology | News

Smartphone-delivered CBT improves glycemic control in people with type 2 diabetes

Findings from a randomized controlled trial published in Diabetes Care suggest that for people with type 2 diabetes, the delivery of cognitive behavioral therapy via a digital therapeutic app, on top of standard of care, may reduce glycated hemoglobin.

09-23-2022 | EASD 2022 | Conference coverage | News

Bolus timing requires more attention in people using advanced technologies for type 1 diabetes

Delayed prandial insulin boluses are common in people using advanced technologies for the management of type 1 diabetes and are associated with adverse glycemic outcomes, suggest real-world study results.

09-21-2022 | EASD 2022 | Conference coverage | News

isCGM benefits sustained for at least 2 years

The improved glycemic control gained from use of intermittently scanned continuous glucose monitoring is sustained for at least 2 years in people with type 1 diabetes, show real-world data.

09-21-2022 | EASD 2022 | Conference coverage | News

Libre upgrade illustrates power of hypoglycemia alerts

Gaining the use of a low blood glucose alert by switching from the FreeStyle Libre 1 to 2 reduces the amount of time people with type 1 diabetes spend in hypoglycemia, report researchers.

09-07-2022 | Artificial pancreas systems | News

AHCL system benefits people with poorly controlled type 1 diabetes

Use of the MiniMed 780G advanced hybrid closed-loop system leads to greater reductions in glycated hemoglobin levels than conventional treatment in people with poorly controlled type 1 diabetes, ADAPT study data show.

08-23-2022 | Telehealth | News

Comprehensive telehealth success for poorly controlled type 2 diabetes

A randomized trial shows that comprehensive care resulting in improved glycemic control among people with persistently poorly controlled type 2 diabetes can be delivered via telehealth.

07-06-2022 | Artificial pancreas systems | News

Hybrid closed-loop system brings benefits even with lax bolusing

Use of the Tandem Control IQ hybrid closed-loop insulin delivery system improves time in range even for users who very rarely bolus for meals or to treat hyperglycemia, an observational study suggests.

06-13-2022 | Artificial pancreas systems | News

Researchers calculate unannounced snack threshold for closed-loop system

Children and adolescents using an advanced hybrid closed-loop system for type 1 diabetes can tolerate an unannounced snack containing 20 g of carbohydrate without excessive blood sugar fluctuations, Italian researchers report.

06-07-2022 | ADA 2022 | Conference coverage | News

​​​​​​​Artificial intelligence platform shows promise for type 2 diabetes remission

An artificial intelligence platform known as Whole Body Twin could be one answer to reversing type 2 diabetes, research suggests.

05-18-2022 | Empagliflozin | News

Pros and cons with empagliflozin addition to closed-loop insulin

Adding daily empagliflozin to closed-loop insulin delivery improves time in range but also increases ketone levels in people with type 1 diabetes, shows a randomized trial.

05-04-2022 | Artificial pancreas systems | Conference coverage | News

Real-world study probes artificial pancreas system differences

Italian researchers have compared outcomes of children and adults with type 1 diabetes using Medtronic MiniMed 780G and the Tandem Control IQ closed-loop insulin delivery systems in real-world practice.

04-19-2022 | Older adults | News

Sustained benefits of CGM in older people with type 1 diabetes

Follow-up results from the WISDM trial show that extended use of continuous glucose monitoring leads to reduced hypoglycemia without increasing hyperglycemia risk in older people with type 1 diabetes.

03-31-2022 | DUKPC 2022 | Conference coverage | News

Flash UK: isCGM benefits hold up in setting of poor glycemic control

People with type 1 diabetes and poor glycemic control benefit from use of intermittently scanned continuous glucose monitoring versus self-monitored blood glucose, report the Flash UK investigators.

01-10-2022 | COVID-19 | News

COVID-19 vaccination may lead to temporary changes in glucose control

The proportion of on-target interstitial glucose values falls during the week following initial COVID-19 vaccination in people with type 1 diabetes, study findings indicate.

12-14-2021 | Artificial pancreas systems | News

Older age ‘not a barrier’ to closed-loop insulin delivery for type 1 diabetes

Findings from the ORACL trial suggest that closed-loop insulin delivery results in better glycemic control than sensor-augmented pump therapy among older adults with longstanding type 1 diabetes.

10-14-2021 | Flash glucose monitoring | News

Real-world data highlight universal benefits of flash glucose monitoring

Flash glucose monitoring improves glycemic control and reduces diabetic ketoacidosis rates across nearly all age, sex, and sociodemographic strata, regardless of insulin pump use, according to UK observational data.

08-10-2021 | Artificial pancreas systems | News

Closed-loop system improves glycemic control in people with type 2 diabetes on dialysis

Findings from an exploratory randomized crossover trial suggest that closed-loop insulin delivery leads to better glycemic control than standard insulin treatment in people with type 2 diabetes and end-stage renal disease requiring maintenance dialysis in the outpatient setting.

06-27-2021 | ADA 2021 | Conference coverage | News

Early initiation of CGM may improve glycemic control in youth with type 1 diabetes

Use of continuous glucose monitoring within the first month of diagnosis is associated with an improvement in glycemic control among youth with type 1 diabetes, indicate findings from the 4T study.

Flash glucose monitoring

06-02-2021 | ATTD 2021 | Conference coverage | News

ALERTT1: Time in range, hypoglycemia worry improve with isCGM to rtCGM switch

Switching from intermittently scanned to real-time continuous glucose monitoring improves time in range by a clinically relevant percentage, show the findings of the 6-month ALERTT1 trial.